Chen, Hsing-YuHsing-YuChenFang, Wei-ChingWei-ChingFangChu, Shao-ChiShao-ChiChuWang, Po-HsiPo-HsiWangLee, Chin-ChanChin-ChanLeeWu, I-WenI-WenWuSun, Chiao-YinChiao-YinSunHsu, Heng-JungHeng-JungHsuChen, Chun-YuChun-YuChenChen, Yung-ChangYung-ChangChenVIN-CENT WUPan, Heng-ChihHeng-ChihPan2023-02-152023-02-1520232218-273Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/628168Fibroblast growth factor-23 (FGF-23) associates with decreased kidney function in patients with chronic kidney disease (CKD). However, the correlation between circulating FGF-23 levels and the rate of renal function decline in healthy individuals is largely unknown. We aimed to evaluate the predictive performance of FGF-23 for rapid kidney function decline (RKFD) in a community-based study.enFGF-23; biomarker; chronic kidney disease; rapid kidney function decline[SDGs]SDG3Circulating Fibroblast Growth Factor-23 Levels Can Predict Rapid Kidney Function Decline in a Healthy Population: A Community-Based Studyjournal article10.3390/biom13010031366714162-s2.0-85146683808WOS:000916996300001https://api.elsevier.com/content/abstract/scopus_id/85146683808